Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.

MLA

Scriba, Thomas J., et al. “Biomarker-Guided Tuberculosis Preventive Therapy (CORTIS): A Randomised Controlled Trial.” The Lancet. Infectious Diseases, vol. 21, no. 3, Mar. 2021, pp. 354–65. EBSCOhost, https://doi.org/10.1016/S1473-3099(20)30914-2.

APA

Scriba, T. J., Fiore-Gartland, A., Penn-Nicholson, A., Mulenga, H., Kimbung Mbandi, S., Borate, B., Mendelsohn, S. C., Hadley, K., Hikuam, C., Kaskar, M., Musvosvi, M., Bilek, N., Self, S., Sumner, T., White, R. G., Erasmus, M., Jaxa, L., Raphela, R., Innes, C., … Hatherill, M. (2021). Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial. The Lancet. Infectious Diseases, 21(3), 354–365. https://doi.org/10.1016/S1473-3099(20)30914-2

Chicago

Scriba, Thomas J, Andrew Fiore-Gartland, Adam Penn-Nicholson, Humphrey Mulenga, Stanley Kimbung Mbandi, Bhavesh Borate, Simon C Mendelsohn, et al. 2021. “Biomarker-Guided Tuberculosis Preventive Therapy (CORTIS): A Randomised Controlled Trial.” The Lancet. Infectious Diseases 21 (3): 354–65. doi:10.1016/S1473-3099(20)30914-2.